Dr. Esteva on Next-Generation Sequencing in Metastatic Breast Cancer

Francisco J. Esteva, MD, PhD
Published: Friday, Sep 08, 2017



Francisco J. Esteva, MD, PhD, medical oncologist, NYU Langone Medical Center, discusses next-generation sequencing in metastatic breast cancer.

Next-generation sequencing is not yet recommended as the standard of care by the FDA, though it is used at many large institutions.

Esteva says that the goal with this sequencing would allow treating physicians to direct their patients to appropriate clinical trials.
 


Francisco J. Esteva, MD, PhD, medical oncologist, NYU Langone Medical Center, discusses next-generation sequencing in metastatic breast cancer.

Next-generation sequencing is not yet recommended as the standard of care by the FDA, though it is used at many large institutions.

Esteva says that the goal with this sequencing would allow treating physicians to direct their patients to appropriate clinical trials.
 

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Cancer Summaries and Commentaries™: Update from Chicago: Advances in the Treatment of Breast CancerJul 31, 20181.0
Community Practice Connections™: Medical Crossfire®: Translating Lessons Learned with PARP Inhibition to the Treatment of Breast Cancer—Expert Exchanges on Novel Strategies to Personalize CareAug 29, 20181.5
Publication Bottom Border
Border Publication
x